Presented at the European Society for Medical Oncology Immuno-Oncology Congress 2019
Collaborator: Bristol-Myers Squibb France
Authors: Ophélie Wilczynski, Anthony Boisbouvier, Lise Radoszycki, François-Emery Cotte, Anne-Françoise Gaudin, Hervé Lemasson
Preserving the health related quality of life (HRQoL) of cancer patients is a major goal of clinicians and health authorities. Routine monitoring of PROs in daily clinical practice has demonstrated improvements in symptom management, patient satisfaction with care, levels of supportive care use, clinician/patient communication, HRQoL and overall survival. The study objective was to describe patients’ experience and expectations regarding HRQoL, in particular in their relationship with oncologists/radiotherapists.